BESPONSA DIN 02473909
Health Canada record
| Active ingredient(s) | INOTUZUMAB OZOGAMICIN 0.9 MG |
|---|---|
| Dosage form | Powder For Solution |
| Route | Intravenous |
| Schedule | PRESCRIPTION; SCHEDULE D |
| Class | Human |
| ATC | L01FB01 INOTUZUMAB OZOGAMICIN |
| Original market date | 03-May-2018 |
| Current status date | 03-May-2018 |
| Source | Health Canada DPD |
Establishment licence of the holder
Pfizer Canada ULC — licence 100255, currently licensed, last inspection rating C (2023-08-07).
No Canadian shortage report is currently matched to this DIN.
Request a quote for BESPONSA